Rekha Hemrajani sold $22k of MXCT
director at MAXCYTE, INC.. 10,684 shares at an average of $2.09, traded Jun 25, 2025, filed Aug 27, 2025.
Score components
- +15RoleDirector
- 0Trade size$22k at market
- +5Share of holdings soldSold 21% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-25-003155, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 25, 2025 | SOpen-market sale Common Stock10b5-1 | -10,684 | $2.09 | $22k | 39,893 | Aug 27, 2025 |
Related signals
Other insiders at MAXCYTE, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | MXCTsell MAXCYTE, INC. | Douglas J Swirsky CHIEF FINANCIAL OFFICER | $8,266 10,142 shares | -6% | |
| 62Notable | MAXCYTE, INC. | William W Brooke director | $65k 50,000 shares | +50% | |
| 68Notable | MAXCYTE, INC. | Richard Douglas director | $111k 80,000 shares | +53% | |
| 65Notable | MAXCYTE, INC. | Stanley C Erck director | $137k 100,000 shares | +34% | |
| 78Notable | MAXCYTE, INC. | Maher Masoud President and CEO | $103k 75,000 shares | +75% | |
| 69Notable | MAXCYTE, INC. | Douglas J Swirsky CHIEF FINANCIAL OFFICER | $65k 50,000 shares | +45% | |
| 0Weak | MAXCYTE, INC. | John Joseph Johnston director | $14k 3,000 shares | -2% | |
| 0Weak | MAXCYTE, INC. | John Joseph Johnston director | $12k 3,000 shares | -2% | |
| 0Weak | MAXCYTE, INC. | John Joseph Johnston director | $11k 3,000 shares | -2% | |
| 5Weak | MAXCYTE, INC. | Stanley C Erck director | $177k 47,689 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.